Advertisement AutoGenomics granted patent for HPV detection - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

AutoGenomics granted patent for HPV detection

AutoGenomics has received a key European patent for human papillomavirus. This new patent pertains to a method for detecting the presence of HPV using a microarray.

Fareed Kureshy, president and CEO of AutoGenomics, said: “This patent is the result of our collaboration with Dr Erik Thunnissen, a prominent clinician and opinion leader in the field of human papillomavirus (HPV).

“with increasing demands for alternative technologies to meet the evolving need for genotyping we are excited that we can offer an automated solution that can significantly enhance workflow efficiency in the laboratory.”